Navigation Links
Osteoplug Bioresorbable Implant for Trephination Burr Holes

ProductsOsteoplug Bioresorbable Implant for Trephination Burr Holes
Company Osteopore International
Item Osteoplug Bioresorbable Implant for Trephination Burr Holes
Features 
  • Excellent long-term clinical results
  • FDA-cleared for craniofacial indications
  • Easy handling and application
  • Mechanical properties close to human cancellous bone
  • No foreign body reaction
  • Safe
  • Obviates the need for external fixation
  • A plethora of sizes and shapes can be produced
Description Posteoplug is a bioresorbable implant that is used for covering trephination burr holes in neurosurgery. This proprietary, user-friendly design, shaped like a flattened button mushroom, allows a snap fit into burr holes and requires no fixation by screws, unlike titanium plates. It has superior mechanical strength and the scaffold architecture minimizes potential injuries to the exposed brain through the burr holes. Its interconnecting porous matrix architecture allows it to be rapidly saturated with marrow, blood and nutrients for bone growth and remodeling. Long-term clinical trials showed significant bone regeneration, re-covering the burr hole as the material is slowly resorbed by the body and replaced by autologous bone.
Info Osteopore International
Customer Service: +65 67758625
Web site: http://www.osteopore.com.sg/

Related medicine products :

1. Osteomesh Bioresorbable Implant for Craniofacial Surgery
2. Meridional Implant (106 Style)
3. Meridional Implant (103 Style)
4. Meridional Implant (112 Style)
5. Cylindrical Sponge Implants - 3.0 x 80 mm
6. Olk Design Sponge Implants - 5.0 x 2.5 x 80 mm
7. Olk Design Sponge Implants - 7.5 x 2.75 x 80 mm
8. Cylindrical Sponge Implants - 4.0 x 80 mm
9. Cylindrical Sponge Implants - 5.0 x 80 mm
10. Oval Sponge Implants - 5.5 x 7.5 x 80 mm
11. Oval Sponge Implants - 3.0 x 5.0 x 100 mm
Jewelers Forceps, delicate, straight....
2 mm wide tip with 1 mm by 4 mm eye. Curved shaft and ring handle with polished finish....
Straight iris forceps. Insulated....
Hardy bayonet forceps with stops. Insulated....
Medicine Products:
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... A recent ... that most people are unfamiliar with. The article goes on to state that individuals ... also many of these less common operations such as calf and cheek reduction. The ...
(Date:6/24/2016)... ... 24, 2016 , ... June 19, 2016 is World Sickle Cell Observance Day. ... the benefits of holistic treatments, Serenity Recovery Center of Marne, Michigan, has ... , Sickle Cell Disease (SCD) is a disorder of the red blood cells, which ...
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension Association (PHA) ... will receive two significant new grants to support its work to advance research ... anniversary by recognizing patients, medical professionals and scientists for their work in fighting ...
(Date:6/24/2016)... ... June 24, 2016 , ... Dr. Amanda Cheng, an ... Dr. Cheng has extensive experience with all areas of orthodontics, including robotic Suresmile ... orthodontics. , Micro-osteoperforation is a revolutionary adjunct to orthodontic treatment. It can ...
(Date:6/24/2016)... ... , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business ... to $12 an hour by 2020 and then adjusting it yearly to increase at the ... minimum wage, assure the wage floor does not erode again, and make future increases more ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Tenn. , June 24, 2016  Arkis ... providing less invasive and more durable cerebrospinal fluid ... in funding.  The Series-A funding is led by ... Lighthouse Fund, and other private investors.  Arkis, new ... neurosurgical instrumentation and the market release of its ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: